Related Experiment Video
Updated: Mar 2, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Management of Patients with Atrial Fibrillation: Focus on Treatment Options
Pawel Matusik1,2, Jacek Lelakowski1,3, Barbara Malecka1,3
1Department of Electrocardiology, The John Paul II Hospital, Kraków, Poland.
Insights
Atrial fibrillation (AF) diagnosis uses ECG, Holter, and implantable devices. Treatment involves rhythm/rate control, pharmacotherapy, nonpharmacological methods, and advanced procedures like ablation and device implantation.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with significant clinical impact.
- Diagnosis typically relies on electrocardiogram (ECG) or Holter monitoring, with increasing use of event recorders and implantable devices.
Purpose of the Study:
- To review and discuss current and emerging treatment strategies for patients with atrial fibrillation.
- To cover pharmacotherapy, nonpharmacological interventions, and device-based therapies.
Main Methods:
- Review of current literature on atrial fibrillation diagnosis and management.
- Discussion of established and novel therapeutic approaches, including pharmacotherapy, cardioversion, ablation, and device therapies.
Main Results:
- Established diagnostic tools include ECG, Holter, event recorders, and CIED.
- Treatment encompasses pharmacotherapy (including anticoagulants), rhythm/rate control, nonpharmacological management, electrical cardioversion, catheter ablation, surgical options, and left atrial appendage occlusion.
- Cardiovascular implantable electronic devices (CIEDs) like pacemakers and defibrillators are crucial for rate and rhythm control, with novel pacing strategies emerging.
Conclusions:
- A comprehensive approach integrating pharmacotherapy, lifestyle modifications, and advanced procedural techniques is essential for managing AF.
- Novel pacing strategies and device-based interventions offer promising future directions in AF treatment.
Abstract:
Atrial fibrillation (AF) is leading cardiac arrhythmia with important clinical implications. Its diagnosis is usually made on the basis on 12-lead ECG or 24-hour Holter monitoring. More and more clinical evidence supports diagnostic use of cardiac event recorders and cardiovascular implantable electronic devices (CIED). Treatment options in patients with atrial fibrillation are extensive and are based on chosen rhythm and/or rate control strategy. The use and selected contraindications to AF related pharmacotherapy, including anticoagulants are shown. Nonpharmacological treatments, comorbidities and risk factors control remain mainstay in the treatment of patients with AF. Electrical cardioversion consists important choice in rhythm control strategy. Much progress has been made in the field of catheter ablation and cardiac surgery methods. Left atrial appendage occlusion/closure may be beneficial in patients with AF. CIED are used with clinical benefits in both, rhythm and rate control. Pacemakers, implantable cardioverter-defibrillators and cardiac resynchronization therapy devices with different pacing modes have guaranteed place in the treatment of patients with AF. On the other hand, the concepts of permanent leadless cardiac pacing, atrial dyssynchrony syndrome treatment and His-bundle or para-Hisian pacing have been proposed. This review summarizes and discusses current and novel treatment options in patients with atrial fibrillation.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Mitral Stenosis III: Medical Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management

